Article

Sightpath Medical marks milestone for improved vision in 2 million eyes

Sightpath Medical announced a significant milestone-improving the sight of 2 million eyes.

Chicago-Sightpath Medical announced a significant milestone-improving the sight of 2 million eyes.

The provider of mobile equipment and services for cataract surgery, laser cataract surgery, and refractive surgery partners with more than 1,300 surgeons in 850 facilities and assists with more than 100,000 ophthalmic procedures each year on both a fixed and mobile basis.

“We’re excited to celebrate this milestone with the ophthalmology community and to express our sincere gratitude to every individual we have worked with throughout our 23-year history,” said Peter Flynn, president and chief executive officer of Sightpath Medical. “Looking forward, we promise to continue our commitment as a trusted partner and resource for innovation and ingenuity.”

The company celebrated the achievement during a reception here at the Chicago Illuminating Co. on Sunday evening at the annual meeting of the American Academy of Ophthalmology.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.